Dynamic monitoring serum tumor markers to predict molecular features of EGFR‐mutated lung cancer during targeted therapy

To reveal the correlation of dynamic serum tumor markers (STMs) and molecular features of epidermal growth factor receptor‐mutated (EGFR‐mutated) lung cancer during targeted therapy, we retrospectively reviewed 303 lung cancer patients who underwent dynamic STM tests [neuron‐specific enolase (NSE),...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Zhuxing, Liu, Liping, Zhu, Feng, Cai, Xiuyu, Zhao, Yi, Liang, Peng, Ou, Limin, Zhong, Ran, Yu, Ziwen, Li, Caichen, Li, Jianfu, Xiong, Shan, Feng, Yi, Cheng, Bo, Liang, Hengrui, Xie, Zhanhong, Liang, Wenhua, He, Jianxing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9385589/
https://www.ncbi.nlm.nih.gov/pubmed/35543090
http://dx.doi.org/10.1002/cam4.4676

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9385589/
https://www.ncbi.nlm.nih.gov/pubmed/35543090
http://dx.doi.org/10.1002/cam4.4676

Ejemplares similares